Akiko Okamoto

Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety

Fred Grossman, S. Nassir Ghaemi, Akiko Okamoto et al. · American Journal of Psychiatry · 2002 · 410 citations

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

Sherwyn Schwartz, Mila Etropolski, Douglas Y. Shapiro et al. · Current Medical Research and Opinion · 2010 · 256 citations

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

Robert Buynak, Douglas Y. Shapiro, Akiko Okamoto et al. · Expert Opinion on Pharmacotherapy · 2010 · 250 citations

Characterization of antibodies to the rat substance P (NK-1) receptor and to a chimeric substance P receptor expressed in mammalian cells

SR Vigna, DM McDonald, Jacob C. Fisher et al. · Journal of Neuroscience · 1994 · 228 citations · Full text

Immunology, Immunodominance, Immunologic Mechanism +20

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

Marc Afilalo, Mila Etropolski, Brigitte Kuperwasser et al. · Clinical Drug Investigation · 2010 · 226 citations

Pain Therapy, Health Sciences, Pain Medicine +10